Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Mulligan BioCapital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 6
Average round size
info
The average size of a deal this fund participated in
$11M
Portfolio companies 5
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.17
Exits 3
Key employees Soon
Stages of investment
Late Stage Venture

Areas of investment

  • Biotechnology
  • Medical
  • Other Pharmaceuticals and Biotechnology
  • Biomass Energy
  • Industrial
Summary

The venture was found in Europe in Germany. The main department of described VC is located in the Hamburg.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Mulligan BioCapital, startups are often financed by Techno Venture Management, Sanders Morris Harris, Deutsche Venture Capital. The meaningful sponsors for the fund in investment in the same round are Techno Venture Management, Deutsche Venture Capital, BioMedPartners. In the next rounds fund is usually obtained by TVM Capital, NRW.BANK, Wellington Partners.

The higher amount of exits for fund were in 2014. The fund is constantly included in less than 2 deals per year. Opposing the other organizations, this Mulligan BioCapital works on 21 percentage points more the average amount of lead investments. The important activity for fund was in 2004. The common things for fund are deals in the range of 10 - 50 millions dollars.

Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline 4SC, Cardion, 4-Antibody AG Among the most popular fund investment industries, there are Biopharma, Genetics. For fund there is a match between the location of its establishment and the land of its numerous investments - Germany.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Mulligan BioCapital:
Typical Co-investors
Mulligan BioCapital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Mulligan BioCapital:

Funds with similar focus

Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

DIREVO Industrial Biotechnology

Biomass Energy
Biotechnology
Industrial
Other Pharmaceuticals and Biotechnology
$16M18 Oct 2007 Cologne, North Rhine-Westphalia, Germany

Spinal Cord Therapeutics GmbH

Health Care
Medical
Pharmaceutical
$15M19 Sep 2005 Germany, North Rhine-Westphalia, Germany

4-Antibody AG

Biotechnology
Health Care
Medical
Therapeutics
$3M17 Mar 2004 Basel, Basel-City, Switzerland

Biopharma
Biotechnology
Therapeutics
$10M21 May 2003 Germany, Bavaria, Germany

DIREVO Industrial Biotechnology

Biomass Energy
Biotechnology
Industrial
Other Pharmaceuticals and Biotechnology
$10M18 Dec 2000 Cologne, North Rhine-Westphalia, Germany

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Mulligan BioCapital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 6
Average round size 11M
Peak activity year 2007
Lead investments 0
Follow on index 0.17
Exits 3
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

DIREVO Industrial Biotechnology

Biomass Energy
Biotechnology
Industrial
Other Pharmaceuticals and Biotechnology
$16M18 Oct 2007 Cologne, North Rhine-Westphalia, Germany

Spinal Cord Therapeutics GmbH

Health Care
Medical
Pharmaceutical
$15M19 Sep 2005 Germany, North Rhine-Westphalia, Germany

4-Antibody AG

Biotechnology
Health Care
Medical
Therapeutics
$3M17 Mar 2004 Basel, Basel-City, Switzerland

Biopharma
Biotechnology
Therapeutics
$10M21 May 2003 Germany, Bavaria, Germany

DIREVO Industrial Biotechnology

Biomass Energy
Biotechnology
Industrial
Other Pharmaceuticals and Biotechnology
$10M18 Dec 2000 Cologne, North Rhine-Westphalia, Germany
Crunchbase icon

Content report

The following text will be sent to our editors: